Trial Profile
Efficacy of indacaterol with or without tiotropium bromide in patients with moderate or severe chronic obstructive pulmonary disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Nov 2015
Price :
$35
*
At a glance
- Drugs Indacaterol (Primary) ; Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms GOLDEN-II
- 11 Nov 2015 New trial record